Last 48 quarters of trend data · Healthcare · Life Science Tools
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 68.51 | 67.65 | 60.51 | 61.76 | 27.80 | 52.54 | 52.03 | 76.63 | 35.89 | 41.26 | 40.92 | 116.98 | 32.84 | 359.88 | 104.72 | 7.40 | 32.21 | 54.77 | 25.10 | 31.21 | 33.49 |
| — | +28.8% | +16.3% | -19.4% | -22.5% | +27.3% | +27.2% | -34.5% | +9.3% | -88.5% | -60.9% | +1481.1% | +2.0% | +557.1% | +317.2% | -76.3% | -3.8% | +18.3% | +42.3% | +228.2% | +215.6% | |
| P/S Ratio | 5.88 | 5.81 | 4.36 | 3.50 | 3.55 | 3.54 | 3.99 | 4.78 | 4.67 | 5.67 | 4.68 | 4.99 | 4.85 | 5.12 | 5.25 | 6.24 | 5.98 | 5.35 | 5.02 | 5.73 | 6.20 |
| — | +64.2% | +9.1% | -26.8% | -24.0% | -37.5% | -14.7% | -4.3% | -3.7% | +10.6% | -10.9% | -20.1% | -19.0% | -4.2% | +4.6% | +8.9% | -3.5% | -7.6% | +42.2% | +107.8% | +107.9% | |
| P/B Ratio | 2.42 | 2.33 | 1.76 | 1.39 | 1.51 | 1.34 | 1.52 | 1.66 | 1.78 | 1.96 | 1.65 | 1.65 | 1.71 | 1.79 | 1.89 | 2.10 | 2.40 | 2.16 | 2.51 | 3.07 | 3.57 |
| — | +73.7% | +15.6% | -16.7% | -14.9% | -31.5% | -7.5% | +0.6% | +3.6% | +9.6% | -13.1% | -21.2% | -28.7% | -17.1% | -24.6% | -31.8% | -32.7% | -24.8% | -38.7% | -14.7% | -17.5% | |
| P/FCF | 29.25 | 27.80 | 17.57 | 26.11 | 16.79 | 20.60 | 24.90 | 28.30 | 22.73 | 30.88 | 23.70 | 25.00 | 19.55 | — | — | 99.10 | 39.23 | 25.91 | 57.68 | 21.55 | 21.01 |
| — | +34.9% | -29.4% | -7.8% | -26.1% | -33.3% | +5.1% | +13.2% | +16.2% | — | — | -74.8% | -50.2% | — | — | +359.8% | +86.7% | +50.5% | +255.6% | +174.3% | +140.4% | |
| EV / EBITDA | 25.34 | 24.13 | 19.64 | 17.19 | 15.77 | 16.76 | 17.93 | 21.94 | 16.62 | 20.92 | 18.79 | 21.96 | 20.31 | 20.63 | 20.53 | 23.31 | 21.45 | 23.83 | 15.75 | 16.98 | 17.85 |
| — | +44.0% | +9.5% | -21.6% | -5.1% | -19.9% | -4.6% | -0.1% | -18.1% | +1.4% | -8.5% | -5.8% | -5.3% | -13.4% | +30.4% | +37.3% | +20.1% | +23.4% | +38.2% | +129.7% | +132.8% | |
| EV / EBIT | 55.80 | 48.52 | 43.43 | 41.63 | 29.44 | 39.30 | 37.89 | 49.39 | 33.62 | 35.26 | 35.23 | 67.76 | 74.35 | 54.63 | 46.31 | 91.49 | 33.98 | 44.81 | 23.88 | 26.13 | 22.93 |
| — | +23.5% | +14.6% | -15.7% | -12.4% | +11.5% | +7.5% | -27.1% | -54.8% | -35.5% | -23.9% | -25.9% | +118.8% | +21.9% | +93.9% | +250.2% | +48.2% | +29.4% | +69.4% | +218.8% | +147.9% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.1% | 57.4% | 57.1% | 54.5% | 43.8% | 53.6% | 54.5% | 56.5% | 49.3% | 56.3% | 55.7% | 54.6% | 42.2% | 55.5% | 56.7% | 56.5% | 46.7% | 49.3% | 61.6% | 61.7% | 53.1% |
| — | +7.1% | +4.8% | -3.5% | -11.2% | -4.7% | -2.2% | +3.4% | +16.8% | +1.3% | -1.8% | -3.3% | -9.6% | +12.7% | -7.9% | -8.5% | -12.1% | -13.0% | +16.7% | +7.5% | -10.3% | |
| Operating Margin | 12.5% | 13.1% | 12.2% | 10.7% | 14.5% | 11.7% | 12.6% | 10.9% | 18.1% | 15.0% | 14.7% | 11.4% | 14.3% | 13.9% | 15.7% | 14.2% | 20.3% | 16.8% | 27.4% | 29.1% | 29.8% |
| — | +11.4% | -2.9% | -1.8% | -20.2% | -21.9% | -14.2% | -4.7% | +27.0% | +7.9% | -6.3% | -19.7% | -29.8% | -17.5% | -42.8% | -51.2% | -31.8% | -46.0% | -3.4% | -20.4% | -22.6% | |
| Net Margin | 8.5% | 8.5% | 7.1% | 5.7% | 12.7% | 6.7% | 7.7% | 6.4% | 13.0% | 13.7% | 11.4% | 4.3% | 14.8% | 1.4% | 5.0% | 84.4% | 18.6% | 9.8% | 20.0% | 18.4% | 18.5% |
| — | +28.1% | -7.4% | -9.9% | -2.2% | -51.4% | -33.0% | +49.0% | -11.7% | +864.3% | +128.1% | -94.9% | -20.5% | -85.4% | -74.9% | +359.3% | +0.4% | -21.9% | -0.1% | -36.7% | -34.1% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 3.2% | 0.9% | 0.7% | 0.6% | 1.3% | 0.6% | 0.7% | 0.6% | 1.2% | 1.2% | 1.0% | 0.4% | 1.3% | 0.1% | 0.4% | 7.4% | 1.9% | 1.0% | 2.5% | 2.5% | 2.7% |
| — | +37.5% | -1.1% | +2.2% | +10.3% | -47.5% | -27.8% | +56.5% | -7.6% | +869.1% | +125.1% | -95.2% | -30.7% | -87.4% | -82.1% | +199.1% | -29.4% | -49.2% | -58.2% | -74.8% | -75.3% | |
| ROA | 2.0% | 0.5% | 0.4% | 0.3% | 0.8% | 0.4% | 0.4% | 0.3% | 0.8% | 0.7% | 0.6% | 0.2% | 0.8% | 0.1% | 0.2% | 4.0% | 1.0% | 0.5% | 1.2% | 1.2% | 1.3% |
| — | +39.0% | -3.5% | -1.3% | +7.1% | -46.9% | -24.2% | +66.2% | -0.8% | +938.2% | +139.0% | -94.8% | -22.7% | -86.1% | -80.0% | +233.9% | -22.6% | -45.5% | -56.1% | -73.9% | -75.2% | |
| ROIC | 2.7% | 0.8% | 0.7% | 0.6% | 0.9% | 0.6% | 0.7% | 0.6% | 1.0% | 0.7% | 0.7% | 0.5% | 0.7% | 0.6% | 0.8% | 0.7% | 1.0% | 0.8% | 1.6% | 1.8% | 2.0% |
| — | +20.8% | +1.2% | +5.8% | -14.8% | -16.6% | -2.9% | +8.5% | +45.0% | +15.3% | -9.2% | -22.9% | -30.6% | -18.4% | -51.1% | -63.5% | -49.3% | -64.6% | -63.3% | -71.4% | -73.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.48 | 0.38 | 0.46 | 0.47 | 0.48 | 0.46 | 0.45 | 0.44 | 0.43 | 0.42 | 0.51 | 0.51 | 0.52 | 0.52 | 0.57 | 0.56 | 0.62 | 0.64 | 0.65 | 0.70 | 0.72 |
| — | -16.7% | +3.5% | +7.1% | +11.8% | +9.1% | -12.1% | -14.7% | -16.0% | -19.8% | -11.3% | -9.1% | -17.0% | -18.9% | -12.1% | -20.1% | -13.9% | -15.4% | +8.7% | +1.5% | +21.6% | |
| Debt / EBITDA | 4.61 | 13.96 | 17.46 | 18.52 | 16.37 | 18.31 | 17.44 | 19.60 | 14.01 | 15.77 | 19.14 | 22.01 | 19.84 | 19.92 | 20.48 | 22.02 | 18.02 | 22.36 | 13.19 | 12.95 | 12.27 |
| — | -23.8% | +0.1% | -5.5% | +16.8% | +16.2% | -8.9% | -10.9% | -29.4% | -20.9% | -6.6% | -0.0% | +10.1% | -10.9% | +55.3% | +70.0% | +46.9% | +35.4% | +120.0% | +156.3% | +223.9% | |
| Current Ratio | 1.68 | 2.65 | 1.80 | 1.72 | 1.68 | 1.75 | 3.33 | 3.58 | 3.60 | 3.56 | 2.27 | 2.23 | 2.07 | 2.01 | 2.58 | 2.43 | 2.13 | 2.10 | 2.02 | 1.94 | 2.01 |
| — | +51.3% | -45.9% | -52.0% | -53.2% | -50.7% | +46.5% | +60.6% | +73.9% | +76.9% | -11.8% | -8.3% | -2.8% | -4.1% | +27.7% | +24.9% | +5.9% | +6.7% | +0.3% | +10.5% | +48.4% | |
| Quick Ratio | 1.40 | 2.10 | 1.50 | 1.41 | 1.40 | 1.44 | 2.75 | 2.99 | 3.03 | 2.97 | 1.98 | 1.92 | 1.77 | 1.71 | 2.26 | 2.15 | 1.87 | 1.84 | 1.42 | 1.43 | 1.66 |
| — | +45.5% | -45.3% | -53.0% | -54.0% | -51.4% | +38.7% | +55.2% | +71.1% | +73.6% | -12.2% | -10.6% | -5.0% | -7.2% | +58.9% | +50.3% | +12.4% | +31.5% | -8.6% | +1.5% | +59.1% | |
| Interest Coverage | 3.91 | 4.73 | 3.76 | 3.02 | 4.89 | 3.45 | 3.99 | 3.28 | 5.15 | 5.12 | 4.51 | 2.42 | 2.28 | 2.99 | 3.75 | 2.29 | 7.15 | 4.17 | 8.61 | 8.92 | 11.81 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying RVTY stock.
Revvity, Inc.'s current P/E is 68.5x. The average P/E over the last 4 quarters is 54.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Revvity, Inc.'s current operating margin is 12.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Revvity, Inc.'s business trajectory between earnings reports.